Article

Kemin launches lutein campaign

Kemin has launched a national marketing campaign to promote its brand of lutein (FloraGLO) and educate consumers about the role lutein plays in maintaining healthy vision.

Des Moines, IA-Kemin has launched a national marketing campaign to promote its brand of lutein (FloraGLO) and educate consumers about the role lutein plays in maintaining healthy vision.

“Nearly half of the U.S. population has low levels of lutein in their eyes, putting them at risk for developing certain eye conditions as they age,” said Linda Fullmer, senior vice president of Kemin. “Too many people are still unaware that there are easy steps, like taking a daily eye vitamin, that can protect, prolong, and improve their visual performance.”

Research indicates that people need 10 mg of lutein every day through diet and eye vitamins, according to the company, and most Americans are getting no more than 2 mg daily through their diets.

The marketing campaign will leverage alliances with the American Optometric Association, Prevent Blindness America, and AMD Alliance International, and will include national programs, doctor education, and consumer outreach. Involved in the campaign will be visually impaired national and world triathlon champion Aaron Scheidies; model Emme; track and field athlete Lolo Jones; and nutritionist and fitness expert Jennifer Galardi.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.